Literature DB >> 3032637

Stress induced right ventricular dysfunction: an indication of reversible right ventricular ischaemia.

S R Underwood, D Campos Costa, S Walton, P J Laming, P J Ell, R W Emanuel, R H Swanton.   

Abstract

Stress induced changes in left ventricular ejection fraction are widely used in the detection and assessment of coronary artery disease. This study demonstrates that right ventricular dysfunction may also occur, and assesses its significance in terms of coronary artery anatomy. This study involved 14 normal subjects and 26 with coronary artery disease investigated by equilibrium radionuclide ventriculography, at rest and during maximal dynamic exercise. Mean normal resting right ventricular ejection fraction (RVEF) was 0.40 (SD 0.118), and all normal subjects increased RVEF with stress (mean delta RVEF + 0.13 SD 0.099). Mean delta RVEF in the subjects with coronary artery disease was significantly lower at 0.00 (SD 0.080), but there was overlap between the two groups. The largest falls in RVEF were seen if the right coronary artery was occluded without retrograde filling. In this subgroup with the most severely compromised right ventricular perfusion (nine subjects), RVEF always fell with stress, and mean delta RVEF was -0.08 (SD 0.050). There was no significant correlation between delta LVEF and delta RVEF, implying that the right ventricular dysfunction was due to right ventricular ischaemia, rather than secondary to left ventricular dysfunction. Stress induced right ventricular ischaemia can therefore be detected readily by radionuclide ventriculography.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3032637     DOI: 10.1007/BF00296091

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  18 in total

1.  THE PATHOGENESIS OF INFARCTION OF THE RIGHT VENTRICLE.

Authors:  W G Wade
Journal:  Br Heart J       Date:  1959-10

2.  A new technique for assessing right ventricular ejection fraction using rapid multiple-gated equilibrium cardiac blood pool scintigraphy. Description, validation and findings in chronic coronary artery disease.

Authors:  J Maddahi; D S Berman; D T Matsuoka; A D Waxman; K E Stankus; J S Forrester; H J Swan
Journal:  Circulation       Date:  1979-09       Impact factor: 29.690

3.  Right ventricular infarction. Clinical and hemodynamic features.

Authors:  J N Cohn; N H Guiha; M I Broder; C J Limas
Journal:  Am J Cardiol       Date:  1974-02       Impact factor: 2.778

4.  Vascular pattern of myocardium of right ventricle of human heart.

Authors:  G Farrer-Brown
Journal:  Br Heart J       Date:  1968-09

5.  Assessment of right ventricular function at rest and during exercise in patients with coronary heart disease: a new approach using equilibrium radionuclide angiography.

Authors:  R Slutsky; W Hooper; K Gerber; A Battler; V Froelicher; W Ashburn; J Karliner
Journal:  Am J Cardiol       Date:  1980-01       Impact factor: 2.778

6.  Comparison of upright and supine bicycle exercise in the detection and evaluation of extent of coronary artery disease by equilibrium radionuclide ventriculography.

Authors:  M R Freeman; D S Berman; H Staniloff; U Elkayam; J Maddahi; H J Swan; J Forrester
Journal:  Am Heart J       Date:  1981-08       Impact factor: 4.749

7.  Right ventricular ejection fraction during exercise in patients with coronary artery disease.

Authors:  L L Johnson; D M McCarthy; R R Sciacca; P J Cannon
Journal:  Circulation       Date:  1979-12       Impact factor: 29.690

8.  The noninvasive diagnosis of right ventricular infarction.

Authors:  D N Sharpe; E H Botvinick; D M Shames; N B Schiller; B M Massie; K Chatterjee; W W Parmley
Journal:  Circulation       Date:  1978-03       Impact factor: 29.690

9.  Can right ventricular performance be assessed by equilibrium radionuclide ventriculography?

Authors:  Q F Xue; W MacNee; D C Flenley; W J Hannan; C J Adie; A L Muir
Journal:  Thorax       Date:  1983-07       Impact factor: 9.139

10.  Noninvasive evaluation of right ventricular function.

Authors:  S Walton
Journal:  J R Soc Med       Date:  1983-05       Impact factor: 18.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.